October 23, 2020
October 23rd, 2020
Meeting Minutes: QI Collaborative Clinical Leadership Meeting
Key points:
- Collaborative growth: we now have 25 clinics participating! 19 pediatric and 6 adult clinics.
- Purpose of Clinical Leadership Committee
- Review progress against strategic goals
- Advice on clinical directions and partnerships
- Recommend new CO-PIs for special project
- Discuss new grant ideas and sustainability plans
- 2020 Prospective Clinics: 7 adult and 7 pediatric clinics
- Virtual Learning Session Planning Nov 9-10th Clinical Leadership Highlights
- Two leadership sessions are planned for the learning session
- Agenda will be finalized with Manu and Sarah’s review and ready for distribution early Nov
- QI Goals
- Review QI metrics implementation schedule (3 stages: Monitoring, Insulin Management and Self-Management)
- Review of phase 1 QI goals
- Overview of phase 2 goals and rationale (not finalized)
- TIR (interest in also measuring the coefficient variance)
- Must make sure sites are able to track and collect data for the first three proposed measures
- Other measures may indirectly affect DKA events and admissions
- Group decided that we should not set quality goals yet for Transition Plans and SDOH since we don’t have a baseline yet. First, we set and improve process and documentation, then we can set goals for the measures.
- Proposing the idea of multiple clinics working together to identify best practices for Transition Plans and SDOH goals
- Use a standard flowsheet for Transition in EMR
- Use standard SDOH sheet from Epic. We are assuming there is similar functionality in Cerner
- Bolus measure is % with at least 3 boluses rather than a mean or median
- Natural language processes will be helpful in the future
- Guest speakers Michael Seid and Beth Mayer-Davis FLEX presentation
- Is this a feasible model to adapt in clinical practice?
- Interest from sites and further action will be taken to set up a time to discuss partnerships
This Post Has 0 Comments